Welcure Drugs & Pharmaceuticals Ltd
Who owns it
Latest filing is 31 Mar 2026. Welcure Drugs & Pharmaceuticals Ltd has not yet filed the Jun 2026 pattern.
Promoter holding has held steady at 0.00% across all 7 quarters on record — no dilution, no exit.
None of the promoter’s holding is pledged, in any quarter of the series.
Loading the quarter figures…
Ownership shown is promoter, public and pledge.
How it trades
Loading trading data…
Splits, bonuses and rights
- 16 Oct 2025
A bonus issue and a stock split took effect the same day. Together, each share became 11, and the price divides by the same factor — a chart falling about 91% is those combined, not a loss.
Shown from Aug 2024, as far back as we can certify the record complete; earlier actions are not listed. Scheduled dividends are listed ahead of their ex-date, and past dividend ex-dates from the same window when on record — a stock with none shown either paid none in that window or predates our records; never read the absence as Welcure Drugs & Pharmaceuticals Ltd having paid none.
Fundamentals and valuation — we hold neither. The FII / DII / government split of public holding — not carried yet.
This page reports what Welcure Drugs & Pharmaceuticals Ltd disclosed to the exchange and how its shares have traded. It states no view on the stock and is not advice. Every figure is dated to the filing it came from; absence is stated, never shown as zero.